Eden Radioisotopes Moves Forward on $1.4B New Mexico Isotope Plant
Eden Radioisotopes has secured state support and key contractors for a $1.4 billion medical isotope facility in New Mexico, a first of its kind in the U.S.
Eden Radioisotopes is advancing a $1.4 billion medical isotope production facility in New Mexico, announcing state backing and the selection of major contractors as the project moves closer to development, the company said Monday.
Kiewit Nuclear Solutions Co. has been chosen as a key partner on the project, joining engineering firm Sargent & Lundy, which continues its existing role. The combination of a specialized nuclear construction firm and an experienced engineering partner signals the company is assembling an execution team suited to the technical demands of radioisotope infrastructure.
Read more Society of Actuaries Names Five New Board Members for 2026-27 →
The New Mexico facility is described as the first of its kind in the United States, positioning Eden Radioisotopes to address what industry observers have long flagged as a domestic vulnerability: the nation's heavy reliance on foreign sources for medical isotopes used in diagnostic imaging and cancer treatment. State-level support adds a political and economic dimension to the project, suggesting local officials see strategic value in hosting such specialized manufacturing capacity.
Medical isotopes have a short shelf life and require proximity to end users, making domestic production a logistical as well as a national-security consideration. A facility of this scale, if completed, could meaningfully shift the supply landscape for hospitals and cancer centers across the country that depend on a steady isotope supply chain.
No construction timeline or completion date was disclosed in the announcement. Continue reading at All Financial Services & Investing.
